In The News Posted November 22, 2020 Share Posted November 22, 2020 SILVER SPRING, Md., Nov. 21, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of...View the full article Quote Link to comment Share on other sites More sharing options...
Recommended Posts